Company Analysis

Theravance Biopharma, Inc. (TBPH)

TBPH · Pharmaceutical Preparations · George Town, Grand Cayman, CA · filing with the SEC since 2013
Grade6.3
◀ Past 5.6● Present 7.4▶ Future 5.4

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 23, 2026Mar 7, 2025Mar 1, 2024Mar 1, 2023Feb 28, 2022Feb 26, 2021Feb 27, 2020Feb 28, 2019Feb 28, 2018Mar 1, 2017
Revenue107,46464,38157,42451,34655,31171,85773,41460,37015,38648,648
Cost of revenue········6,0302,894
Research and development37,41437,64340,62163,392193,657260,953219,248201,348173,887141,712
Selling, general and administrative73,65269,17470,09567,07399,296108,531r106,08197,05895,59284,509
Total operating expenses111,066111,330113,459143,303313,095369,484r325,329299,121275,509229,115
Operating income-3,602-46,949-56,035-91,957-257,784-297,627r-251,915-238,751-260,123-180,467
Interest expense2,4612,5462,3506,3698,547r8,547r31,86210,4828,5471,404
Share of profit of equity-method investments····103,98768,43833,70511,182170·
Other income (expense), net10,1734,8819,1168,5451,1092,8318,39511,9664,789r1,312
Income before income taxes129,247-44,614-49,269-92,815-265,222r-303,343r-241,677-226,085-271,711-180,559
Income tax expense23,35211,8045,9249-151-8,520-5,222-10,56113,69410,110
Income from continuing operations··-55,193-92,824-265,071-294,823····
Income from discontinued operations···964,95665,64516,806····
Net income including non-controlling interests105,895-56,418········
Net income105,895-56,418-55,193872,132-199,426-278,017-236,455-215,524-285,405-190,669
Net income to common shareholders105,895-56,418········
Earnings per share, basic2.10-1.15-1.0011.85-2.87-4.46-4.25···
Earnings per share, diluted2.06-1.15-1.0011.85-2.87-4.46-4.25···
Earnings per share, basic and diluted·····-4.46-4.25-3.99-5.45-4.26
Weighted average shares, basic50,31748,84755,30373,59169,46162,345r55,610r55,07653,703·
Weighted average shares, diluted51,50748,84755,30373,59169,46162,34555,61053,96952,352·
Weighted average shares, basic and diluted·····62,34555,61053,96952,35244,711
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton TBPH · research, not advice